VAERS reports by lot

GSK Flu lot AFLLA673AA: VAERS reports

20 VAERS reports list lot AFLLA673AA as a GSK Flu vaccine, received between 2011-09-08 and 2012-03-23. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
20
Reports
25%
Marked serious
0
With a death outcome
6
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1420%
General / Systemic (non-local)1217%
Neurological1116%
Dermatological (non-injection-site)1014%
Respiratory69%
Musculoskeletal69%
Cardiac / Cardiovascular57%
Gastrointestinal34%
Thrombotic / Hematological11%
Autoimmune / Immune-mediated11%
Allergic / Anaphylactic11%

Where reports came from

U.S. state of the reporter, where given (top 11).

New Jersey4
Minnesota3
Louisiana2
Georgia2
New York2
California2
Connecticut1
Massachusetts1
Virginia1
Mississippi1
Florida1

Reports by month received

2011-094
2011-1011
2011-112
2011-121
2012-021
2012-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.